| 1 |
35052641 | Generation of Hydrogen Peroxide and Downstream Protein Kinase D1 Signaling Is a Common Feature of Inducers of Pancreatic Acinar-to-Ductal Metaplasia. | 2022 Jan 8 |
1 |
| 2 |
35346012 | Diosgenin: mechanistic insights on its anti-inflammatory effects. | 2022 Mar 28 |
1 |
| 3 |
33536192 | Molecular Targeting of RRM2, NF-κB, and Mutant TP53 for the Treatment of Triple-Negative Breast Cancer. | 2021 Apr |
1 |
| 4 |
33766750 | Long non-coding RNAs in the doxorubicin resistance of cancer cells. | 2021 Jun 28 |
1 |
| 5 |
33771682 | Interleukin-6 reverses Adriamycin resistance in nasal NK/T-cell lymphoma via downregulation of ABCC4 and inactivation of the JAK2/STAT3/NF-κB/P65 pathway. | 2021 Jul |
1 |
| 6 |
33773562 | Curcumin Rescues Doxorubicin Responsiveness via Regulating Aurora a Signaling Network in Breast Cancer Cells. | 2021 Mar 1 |
1 |
| 7 |
33775688 | Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells. | 2021 May 1 |
8 |
| 8 |
34343539 | Novel in vivo potential of trifluoperazine to ameliorate doxorubicin-induced cardiotoxicity involves suppression of NF-κB and apoptosis. | 2021 Oct 15 |
1 |
| 9 |
34488792 | Synergy of nanodiamond-doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells. | 2021 Sep 6 |
3 |
| 10 |
34589399 | Combination therapy with miR34a and doxorubicin synergistically inhibits Dox-resistant breast cancer progression via down-regulation of Snail through suppressing Notch/NF-κB and RAS/RAF/MEK/ERK signaling pathway. | 2021 Sep |
3 |
| 11 |
31837803 | Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes. | 2020 Feb 26 |
1 |
| 12 |
32461377 | Long noncoding RNA lnc-LOC645166 promotes adriamycin resistance via NF-κB/GATA3 axis in breast cancer. | 2020 May 27 |
2 |
| 13 |
32685149 | Targeting CD83 in mantle cell lymphoma with anti-human CD83 antibody. | 2020 |
1 |
| 14 |
32774731 | Apatinib-induced NF-κB inactivation sensitizes triple-negative breast cancer cells to doxorubicin. | 2020 |
3 |
| 15 |
33425912 | EGCG Enhanced the Anti-tumor Effect of Doxorubicine in Bladder Cancer via NF-κB/MDM2/p53 Pathway. | 2020 |
4 |
| 16 |
30503721 | A new chemotherapeutic approach using doxorubicin simultaneously with geopropolis favoring monocyte functions. | 2019 Jan 15 |
1 |
| 17 |
30817976 | Insights into the transcriptional regulation of the anthracycline reductase AKR7A2 in human cardiomyocytes. | 2019 Jun 1 |
1 |
| 18 |
30940449 | SENP2 suppresses NF-κB activation and sensitizes breast cancer cells to doxorubicin. | 2019 Jul 5 |
8 |
| 19 |
31412018 | Irisin Enhances Doxorubicin-Induced Cell Apoptosis in Pancreatic Cancer by Inhibiting the PI3K/AKT/NF-κB Pathway. | 2019 Aug 14 |
2 |
| 20 |
29779937 | Estrogen receptor positive breast tumors resist chemotherapy by the overexpression of P53 in Cancer Stem Cells. | 2018 Jun |
1 |
| 21 |
29943786 | Synergistic combination chemotherapy using carrier-free celastrol and doxorubicin nanocrystals for overcoming drug resistance. | 2018 Jul 9 |
1 |
| 22 |
30243823 | Cell-permeable NF-κB inhibitor-conjugated liposomes for treatment of glioma. | 2018 Nov 10 |
1 |
| 23 |
30245930 | The role of miRNAs 34a, 146a, 320a and 542 in the synergistic anticancer effects of methyl 2-(5-fluoro-2-hydroxyphenyl)-1H- benzo[d]imidazole-5-carboxylate (MBIC) with doxorubicin in breast cancer cells. | 2018 |
1 |
| 24 |
30274235 | Chemoresistance in H-Ferritin Silenced Cells: The Role of NF-κB. | 2018 Sep 28 |
1 |
| 25 |
30396468 | The CD44 variant induces K562 cell acquired with resistance to adriamycin via NF-κB/Snail/Bcl-2 pathway. | 2018 Dec |
2 |
| 26 |
33445276 | Bortezomib Increases the Cancer Therapeutic Efficacy of Poly(amino acid)-Doxorubicin. | 2018 Jun 11 |
1 |
| 27 |
27878697 | NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer. | 2017 Jul |
4 |
| 28 |
28036258 | Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk. | 2017 Jan 17 |
4 |
| 29 |
28684738 | Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways. | 2017 Jul 6 |
1 |
| 30 |
28752270 | Combination treatment with dendrosomal nanocurcumin and doxorubicin improves anticancer effects on breast cancer cells through modulating CXCR4/NF-κB/Smo regulatory network. | 2017 Aug |
1 |
| 31 |
29617099 | A Second-Generation Proteasome Inhibitor and Doxorubicin Modulates IL-6, pSTAT-3 and NF-kB Activity in MDA-MB-231 Breast Cancer Cells. | 2017 Jan |
1 |
| 32 |
26842876 | Aspirin Suppresses the Acquisition of Chemoresistance in Breast Cancer by Disrupting an NFκB-IL6 Signaling Axis Responsible for the Generation of Cancer Stem Cells. | 2016 Apr 1 |
1 |
| 33 |
26969380 | Sinapine reverses multi-drug resistance in MCF-7/dox cancer cells by downregulating FGFR4/FRS2α-ERK1/2 pathway-mediated NF-κB activation. | 2016 Mar 15 |
1 |
| 34 |
27055634 | [Abnormal expression of circulating nuclear factor-κB in hepatocellular carcinoma and reversal of multidrug resistance through intervening its gene transcription]. | 2016 Mar 15 |
2 |
| 35 |
27731405 | Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance. | 2016 Oct 12 |
2 |
| 36 |
27741396 | Polycationic Nanofibers for Nucleic Acid Scavenging. | 2016 Nov 14 |
1 |
| 37 |
27784426 | [Role of inhibition of nuclear factor-kappa B gene transcription by specific miRNA in reversing multi-drug resistance of liver cancer]. | 2016 Jul 20 |
1 |
| 38 |
27960162 | The mTORC2/Akt/NFκB Pathway-Mediated Activation of TRPC6 Participates in Adriamycin-Induced Podocyte Apoptosis. | 2016 |
1 |
| 39 |
25400040 | p28(GANK) associates with p300 to attenuate the acetylation of RelA. | 2015 Dec |
1 |
| 40 |
25478729 | Alternation of adriamycin penetration kinetics in MCF-7 cells from 2D to 3D culture based on P-gp expression through the Chk2/p53/NF-κB pathway. | 2015 Jan 15 |
1 |
| 41 |
25704882 | Sumoylation of HDAC2 promotes NF-κB-dependent gene expression. | 2015 Mar 30 |
2 |
| 42 |
25837271 | Alopecurone B reverses doxorubicin-resistant human osteosarcoma cell line by inhibiting P-glycoprotein and NF-kappa B signaling. | 2015 Mar 15 |
1 |
| 43 |
26169986 | Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells. | 2015 Nov |
2 |
| 44 |
26668505 | Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA. | 2015 Dec 7 |
1 |
| 45 |
32262864 | pH-Sensitive pullulan-DOX conjugate nanoparticles for co-loading PDTC to suppress growth and chemoresistance of hepatocellular carcinoma. | 2015 Nov 7 |
4 |
| 46 |
24245692 | Suppression of NF-κB signaling and P-glycoprotein function by gambogic acid synergistically potentiates adriamycin -induced apoptosis in lung cancer. | 2014 |
4 |
| 47 |
24495648 | Sensitization of U937 leukemia cells to doxorubicin by the MG132 proteasome inhibitor induces an increase in apoptosis by suppressing NF-kappa B and mitochondrial membrane potential loss. | 2014 Feb 4 |
1 |
| 48 |
24565101 | MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3. | 2014 Feb 24 |
2 |
| 49 |
24715151 | Doxorubicin induces drug resistance and expression of the novel CD44st via NF-κB in human breast cancer MCF-7 cells. | 2014 Jun |
2 |
| 50 |
24858801 | CXCL12/CXCR4 axis confers adriamycin resistance to human chronic myelogenous leukemia and oroxylin A improves the sensitivity of K562/ADM cells. | 2014 Aug 1 |
1 |